GLYCO-THYMOLINE 55, oromucosal solution bottle, 250 ml
Active ingredients: Sodium benzoate, BORAX, CINÉOLE, LÉVOMENTHOL, Sodium salicylate, Thymol
Commercialized according to BDPM
Solutionbottle, 250 mlvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLYCO-THYMOLINE 55, solution buccale
- Pharmaceutical form
- solution
- Route of administration
- voie buccale autre
- Presentation description
- 1 flacon(s) en verre de 250 mL
- Marketing authorisation holder
- SERP
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Jan 1949
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61989408CIP73045411CIP133400930454114Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVOMENTHOLsolution | 0,037 g · 100 g | SA |
| BENZOATE DE SODIUMsolution | 2,040 g · 100 g | SA |
| THYMOLsolution | 0,037 g · 100 g | SA |
| BORAXsolution | 2,000 g · 100 g | SA |
| CINÉOLEsolution | 0,075 g · 100 g | SA |
| SALICYLATE DE SODIUMsolution | 0,090 g · 100 g | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.